Although we have previously shown efficacy of FTH1 siRNA in a subcutaneous glioblastoma model using astrocytoma cells [24], we found this liposomal formulation had poor transfection efficiency in GICs. This evidence concerns the gene FTH1 and astrocytoma (excluding glioblastoma).